Anzeige
Mehr »
Montag, 23.03.2026 - Börsentäglich über 12.000 News
Das "Next Butte?"-Setup in Montana - und es ist noch immer eine $15M-Story
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CS7H | ISIN: CNE100004JD2 | Ticker-Symbol: 818
Tradegate
19.03.26 | 08:09
2,460 Euro
+0,82 % +0,020
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO LTD Chart 1 Jahr
5-Tage-Chart
ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
2,4002,56022.03.
2,3602,52020.03.

Aktuelle News zur ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiZYLOXTB (02190): NEXT DAY DISCLOSURE RETURN1
DiZylox-Tonbridge Reports 2025 Annual Results with Revenue Exceeding RMB 1.06 Billion and Net Profit Up 143.7% Year-over-Year209HANGZHOU, China, March 17, 2026 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190, "Zylox-Tonbridge" or the "Company") today announced its...
► Artikel lesen
DiZYLOXTB (02190): DISCLOSEABLE TRANSACTION FURTHER ACQUISITION OF THE REMAINING INTEREST IN THE TARGET COMPANY-
DiZYLOXTB (02190): TERMS OF REFERENCE FOR THE REMUNERATION COMMITTEE2
ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY Aktie jetzt für 0€ handeln
DiZYLOXTB (02190): TERMS OF REFERENCE FOR THE NOMINATION COMMITTEE1
DiZYLOXTB (02190): TERMS OF REFERENCE FOR THE AUDIT COMMITTEE-
DiZYLOXTB (02190): PROPOSED CANCELLATION OF THE SUPERVISORY COMMITTEE AND AMENDMENTS TO THE ARTICLES OF ASSOCIATION-
DiZYLOXTB (02190): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025-
DiZylox-Tonbridge Medical Technology Co. Ltd Full Year Income Advances1
DiZYLOXTB (02190): PROPOSED DISTRIBUTION OF 2025 FINAL DIVIDEND; AND CLOSURE OF H SHARE REGISTER OF MEMBERS2
DiZYLOXTB (02190): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025-
02.03.ZYLOXTB (02190): NOTICE OF BOARD MEETING-
13.02.ZYLOXTB (02190): FURTHER INFORMATION IN RELATION TO THE ACQUISITION OF 49% EQUITY INTERESTS IN THE TARGET COMPANY-
29.01.ZYLOXTB (02190): POSITIVE PROFIT ALERT1
16.01.Zylox-Tonbridge übernimmt deutschen Medizintechnik-Hersteller Optimed11
16.01.Zylox-Tonbridge to acquire German medical device firm Optimed2
16.01.Zylox-Tonbridge to Acquire Equity Interest in A European Medical Device Company to Accelerate Expansion in the Global MedTech Market788Marks a major milestone in Zylox-Tonbridge's long-term commitment to global expansionBuilds an integrated global commercialization platform to accelerate Zylox-Tonbridge's adoption of innovative...
► Artikel lesen
15.01.ZYLOXTB (02190): DISCLOSEABLE TRANSACTION ACQUISITION OF 49% EQUITY INTERESTS IN THE TARGET COMPANY1
08.12.25ZYLOXTB (02190): ARTICLES OF ASSOCIATION-
08.12.25ZYLOXTB (02190): AMENDMENTS TO THE ARTICLES OF ASSOCIATION-
Weiter >>
35 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1